參考文獻(xiàn)/References:
[1] Van Rooij I A, Broekmans F J, Hunault C C, et al.Use of ovarian reserve tests for the prediction of ongoing pregnancy in couples with unexplained or mild male infertility[J].Reprod Biomed Online,2006,12(2): 182-190.
[2] Xi Q, Tao Y, Qiu M, et al.Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial[J].Clin Epidemiol, 2020,12: 261-272.
[3] 陳彩虹, 郭藝紅.卵泡期長效長方案促排卵早期思考[J].生殖醫(yī)學(xué)雜志,2019,28(10): 1130-1132.
[4] 李文澍, 包洪初, 張偉, 等.卵泡期長效長方案改善子宮內(nèi)膜異位癥患者IVF/ICSI的臨床結(jié)局[J].中華生殖與避孕雜志,2021,41(6): 496-502.
[5] 柯張紅, 鄭備紅, 孫艷, 等.卵泡期長效長方案在高齡女性中的運(yùn)用分析[J].生殖醫(yī)學(xué)雜志,2021, 30(1): 19-24.
[6] 李娜, 師娟子.激動(dòng)劑長方案中卵巢過度刺激綜合征的預(yù)防[J].生殖醫(yī)學(xué)雜志,2015, 24(10): 783-789.
[7] Albuquerque L E, Saconato H, Maciel M C, et al.Depot versus daily administration of GnRH agonist protocols for pituitary desensitization in assisted reproduction cycles: a Cochrane Review[J].Hum Reprod,2003,18(10): 2008-2017.
[8] Christ J, Herndon C N, Yu B.Severe ovarian hyperstimulation syndrome associated with long-acting GnRH agonist in oncofertility patients[J]. Assist Reprod Genet,2021,38(3): 751-756.
[9] Brown J B.Pituitary control of ovarian function—concepts derived from gonadotrophin therapy[J].Aust N Z J Obstet Gynaecol,1978,18(1): 46-54.
[10] Fauser B C, Van Heusden A M.Manipulation of human ovarian function: physiological concepts and clinical consequences[J].Endocr Rev,1997,18(1): 71-106.
[11] 莫莉菁, 付偉平, 朱琴, 等.聯(lián)合指標(biāo)對多囊卵巢綜合征患者發(fā)生卵巢高反應(yīng)的預(yù)測價(jià)值[J].中國婦幼保健,2021,36(6): 1324-1328.
[12] Sarkar P, Ying L, Plosker S, et al.Duration of ovarian stimulation is predictive of in-vitro fertilization outcomes[J].Minerva Ginecol,2019,71(6): 419-426.
[13] Baker V L, Brown M B, Luke B, et al.Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles[J].Fertil Steril,2015, 104(5): 1145-1152.